
1. General Information
LENVATOL 10 mg Capsule is a prescription anticancer medicine containing Lenvatinib 10 mg. Lenvatinib works by blocking several kinase pathways involved in tumor blood-vessel formation, tumor growth and cancer progression.
Product: LENVATOL 10 mg Capsule
Active ingredient: Lenvatinib 10 mg
Dosage form: Capsule
Therapeutic class: Antineoplastic / Tyrosine Kinase Inhibitor
Manufacturer/Marketer: Cipla Ltd.
Prescription status: Prescription medicine
Phoenix Exim is described here as a medicine exporter from Nagpur, India, serving international markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to applicable pharmaceutical import and export regulations.
2. Product Information
Each LENVATOL 10 mg Capsule contains Lenvatinib equivalent to 10 mg. Lenvatinib is a multi-targeted kinase inhibitor that acts on VEGF receptors and other pathways associated with angiogenesis and cancer growth.
The dosage and treatment schedule depend on the cancer type, treatment combination, overall health, organ function and the patient's response to therapy. Therefore, the dose should be determined by the treating oncologist.
3. Uses of LENVATOL 10 mg
LENVATOL 10 mg may be prescribed for certain forms of:
- Differentiated thyroid cancer, particularly advanced or progressive disease that is radioactive-iodine refractory.
- Hepatocellular carcinoma (liver cancer) when surgery is not appropriate.
- Renal cell carcinoma (kidney cancer) in combination with another anticancer medicine according to the prescribed treatment regimen.
- Advanced or recurrent endometrial cancer in selected patients, generally in combination with pembrolizumab.
The exact indication and combination therapy should always be determined by an oncologist.
4. Benefits of This Medicine
The potential benefits of Lenvatol 10 mg are related to its anticancer activity. It may:
- Help slow the growth and progression of certain tumors.
- Inhibit formation of new blood vessels that tumors use for growth.
- Help control certain advanced or metastatic cancers.
- Reduce or stabilize tumor burden in appropriate patients.
- Support disease management when used as part of an oncologist-directed treatment plan.
It is not a general-purpose medicine and should not be used without a cancer specialist's prescription.
5. Side Effects
Lenvatinib can cause side effects, and their severity varies between patients. Reported adverse effects include:
- High blood pressure
- Diarrhea
- Reduced appetite
- Weight loss
- Fatigue
- Nausea and vomiting
- Headache
- Abdominal pain
- Mouth sores or stomatitis
- Protein in the urine
- Hand-foot syndrome
- Muscle or joint pain
- Changes in voice
- Bleeding/hemorrhage
Serious complications can also occur, including hypertension, cardiac dysfunction, arterial blood clots, liver toxicity, kidney impairment, significant proteinuria, gastrointestinal perforation or fistula, QT prolongation and impaired wound healing.
6. Common Side Effects
Some commonly reported effects include:
- Diarrhea
- High blood pressure
- Tiredness or fatigue
- Decreased appetite
- Nausea
- Vomiting
- Headache
- Weight loss
- Proteinuria
- Mouth inflammation/sores
- Abdominal discomfort
- Hand-foot syndrome
- Joint or muscle pain
If side effects are persistent, severe or unusual, the treating doctor should be contacted promptly.
7. How to Use
- Take LENVATOL 10 mg exactly as prescribed by your oncologist.
- It may generally be taken with or without food.
- Try to take it at approximately the same time each day.
- Swallow the capsule as directed; do not change the dose yourself.
- Do not take an extra dose if you miss one without first following your doctor's instructions.
- The dose may need adjustment or temporary interruption if significant adverse effects occur.
The prescribed dose may differ according to the cancer being treated and whether Lenvatinib is being used alone or with another anticancer medicine.
8. How LENVATOL 10 mg Works
Lenvatinib is a multi-kinase inhibitor. It blocks VEGF receptors VEGFR1, VEGFR2 and VEGFR3, along with other kinase pathways including FGFR1–4, PDGFRA, KIT and RET. These pathways are involved in blood-vessel formation, tumor growth and cancer progression.
By inhibiting these pathways, Lenvatinib can reduce tumor-supporting angiogenesis and help slow cancer growth and progression.
9. Safety Advice
Prescription only: Use only under qualified oncology supervision.
Pregnancy: Lenvatinib can cause fetal harm. Women who can become pregnant should use effective contraception as advised by their doctor.
Blood pressure: Blood pressure should be monitored because hypertension is a common and potentially serious adverse effect.
Heart and blood vessels: Tell your doctor about previous heart disease, blood clots, stroke or other cardiovascular problems.
Liver and kidneys: Your doctor may monitor liver and kidney function during treatment.
Bleeding: Inform your doctor about unusual bleeding or if you take medicines that increase bleeding risk.
Surgery: Lenvatinib can interfere with wound healing, so tell your surgeon and oncologist before any planned procedure.
Drug interactions: Tell your doctor about all prescription medicines, over-the-counter medicines, supplements and herbal products you use.
Breastfeeding: Breastfeeding is generally not recommended during treatment; discuss this with your treating physician.
10. Frequently Asked Questions (FAQs)
Q1. What is LENVATOL 10 mg Capsule?
LENVATOL 10 mg is an anticancer capsule containing Lenvatinib 10 mg. It is used for certain types of thyroid, liver, kidney and endometrial cancers.
Q2. What is the active ingredient in LENVATOL 10 mg?
It contains Lenvatinib 10 mg.
Q3. Can LENVATOL 10 mg be taken without a prescription?
No. It is a prescription anticancer medicine and should be taken only under medical supervision.
Q4. Can LENVATOL 10 mg be taken with food?
It can generally be taken with or without food, but it should be taken consistently according to the doctor's instructions.
Q5. Does LENVATOL cure cancer?
It is used to treat and control certain cancers, but whether it can achieve remission or control disease varies according to the cancer type and individual patient.
Q6. Can the dose be changed by the patient?
No. Dose changes should only be made by the treating oncologist because Lenvatinib can cause significant adverse effects.
Q7. What should I do if I experience severe side effects?
Contact your treating healthcare professional immediately. Serious symptoms such as severe bleeding, chest pain, severe abdominal pain, significant shortness of breath or very high blood pressure require urgent medical attention.
11. Substitute for LENVATOL 10 mg
Because LENVATOL contains Lenvatinib 10 mg, other Lenvatinib 10 mg products may be considered alternatives only when approved and prescribed by a doctor. Examples of products containing Lenvatinib include:
- Lenvat 10 mg Capsule – Natco Pharma
- Lenvima 10 mg Capsule – Lenvatinib brand
- Other approved Lenvatinib 10 mg generic products, depending on the country and availability.
A substitute should not be selected based only on the brand name. The active ingredient, strength, dosage form, manufacturer, regulatory approval and prescribed treatment regimen should be checked by a healthcare professional.
12. Keywords
LENVATOL 10 mg Capsule, Lenvatol 10 mg, Lenvatinib 10 mg Capsule, Lenvatinib 10 mg exporter, Lenvatol 10 mg exporter India, Lenvatol 10 mg supplier India, Lenvatinib capsule exporter from India, Lenvatinib 10 mg pharmaceutical exporter, Lenvatol 10 mg medicine exporter, Lenvatol 10 mg wholesale supplier, Lenvatinib 10 mg wholesale exporter, Lenvatol 10 mg supplier Nagpur, Lenvatinib medicine exporter Nagpur India, Lenvatol 10 mg for thyroid cancer, Lenvatinib for liver cancer, Lenvatinib for kidney cancer, Lenvatinib for endometrial cancer, Lenvatol 10 mg capsules supplier, Lenvatol 10 mg international pharmaceutical supplier, Lenvatinib 10 mg export to USA, Lenvatinib 10 mg export to UK, Lenvatinib 10 mg export to Australia, Lenvatinib 10 mg export to Singapore, Lenvatinib 10 mg export to Canada, Lenvatinib 10 mg export to South Korea, Lenvatinib 10 mg export to UAE, Phoenix Exim Lenvatinib supplier, Phoenix Exim pharmaceutical exporter, Lenvatol 10 mg medicine supplier from India.sual bleeding or if you take medicines that increase bleeding risk. SurgeryKeywords







